(Q72009136)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7654797%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

title

Musculoskeletal complications of systemic lupus erythematosus in the Hopkins Lupus Cohort: an update (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7654797%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

Musculoskeletal complications of systemic lupus erythematosus in the hopkins lupus cohort: An update (English)

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

systemic lupus erythematosus

21 July 2024

main subject

0 references

1

Petri M

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7654797%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

author name string

M. Petri

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7654797

21 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7654797

21 July 2024

publication date

1 September 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7654797%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

22 October 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.1790080305

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.1790080305

21 July 2024

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

Arthritis Care and Research

21 July 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7654797%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7654797%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7654797%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

page(s)

137-145

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7654797%20AND%20SRC:MED&resulttype=core&format=json

Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study

22 October 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

Morbidity of systemic lupus erythematosus: role of race and socioeconomic status

21 July 2024

3

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

Avascular osteonecrosis in patients with SLE: relation to corticosteroid therapy and anticardiolipin antibodies

21 July 2024

5

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients

21 July 2024

6

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus

21 July 2024

7

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

Avascular necrosis of bone in systemic lupus erythematosus: possible role of haemostatic abnormalities

21 July 2024

8

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

Avascular necrosis associated with anticardiolipin antibodies

21 July 2024

9

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

Assessment of the effect of oral corticosteroids on bone mineral density in systemic lupus erythematosus: a preliminary study with dual energy x ray absorptiometry

21 July 2024

12

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

Loss of trabecular bone mineral density in systemic lupus erythematosus

21 July 2024

14

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

Generalised bone loss in patients with early rheumatoid arthritis

21 July 2024

15

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

Bone metabolism in rheumatoid arthritis; relation to disease activity

21 July 2024

16

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

Interleukin-4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo model of bone resorption in rheumatoid arthritis

21 July 2024

17

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

Drug-induced disorders of vitamin D and mineral metabolism

21 July 2024

20

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

Glucocorticoid-Induced Osteoporosis: Pathogenesis and Management

21 July 2024

21

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomized, controlled study

21 July 2024

22

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

Bone loss in adults receiving alternate day glucocorticoid therapy. A comparison with daily therapy

21 July 2024

23

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

Recovery from steroid-induced osteoporosis

21 July 2024

24

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

Glucocorticoid-induced osteoporosis in the lumbar spine, forearm, and mandible of nephrotic patients: a double-blind study on the high-dose, long-term effects of prednisone versus deflazacort

21 July 2024

25

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

Physical activity as a determinant of bone conservation in the radial diaphysis in rheumatoid arthritis

21 July 2024

26

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

Effect of exercise on the bone mineral density and bone remodelling indices in women with rheumatoid arthritis: 2 case studies

21 July 2024

27

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

The bone density of female twins discordant for tobacco use

21 July 2024

28

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus

21 July 2024

29

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

Oestrogens, bones and systemic lupus erythematosus

21 July 2024

30

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

Diclofenac sodium inhibits bone resorption in postmenopausal women

21 July 2024

31

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

Mineralisation defects with pamidronate therapy for Paget's disease

21 July 2024

33

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy

21 July 2024

34

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

Posttransplantation bone disease

21 July 2024

35

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration

21 July 2024

37

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

Calcium supplements in the prevention of steroid-induced osteoporosis

21 July 2024

39

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

Intermittent cyclical etidronate in the prevention of corticosteroid-induced bone loss

21 July 2024

41

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone loss

21 July 2024

43

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

Increased bone density in patients on steroids with etidronate

21 July 2024

45

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD)

21 July 2024

46

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

Prevention of glucocorticoid-induced osteoporosis

21 July 2024

47

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

Prevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients

21 July 2024

48

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

Salmon calcitonin in the therapy of corticoid-induced osteoporosis

21 July 2024

50

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss

21 July 2024

54

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

Effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients treated with and without steroids

21 July 2024

55

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

Adjuvant oestrogen treatment increases bone mineral density in postmenopausal women with rheumatoid arthritis

21 July 2024

57

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

Postmenopausal bone loss in rheumatoid arthritis: effect of estrogens and androgens

21 July 2024

58

1 reference

https://api.crossref.org/works/10.1002/ART.1790080305

21 July 2024

Identifiers

0 references

1 reference